Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D. Apostolaki S, et al. Among authors: papadopoulos s. Breast Cancer Res Treat. 2009 Oct;117(3):525-34. doi: 10.1007/s10549-008-0239-3. Epub 2008 Nov 19. Breast Cancer Res Treat. 2009. PMID: 19016323
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V, Mavroudis D, Perraki M, Papadopoulos S, Apostolaki S, Stathopoulos E, Stathopoulou A, Lianidou E, Georgoulias V. Bozionellou V, et al. Among authors: papadopoulos s. Clin Cancer Res. 2004 Dec 15;10(24):8185-94. doi: 10.1158/1078-0432.CCR-03-0094. Clin Cancer Res. 2004. PMID: 15623593
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Kostopoulos I, Arapantoni-Dadioti P, Gogas H, Papadopoulos S, Malamou-Mitsi V, Scopa CD, Markaki S, Karagianni E, Kyriakou V, Margariti A, Kyrkou E, Pavlakis K, Zaramboukas T, Skordalaki A, Bourli A, Markopoulos C, Pectasides D, Dimopoulos MA, Skarlos D, Fountzilas G. Kostopoulos I, et al. Among authors: papadopoulos s. Breast Cancer Res Treat. 2006 Apr;96(3):251-61. doi: 10.1007/s10549-005-9062-2. Breast Cancer Res Treat. 2006. PMID: 16538542 Clinical Trial.
Comparison of HER2 detection methods between central and regional laboratories in Greece.
Papadopoulos S, Kouvatseas G, Skarlos D, Malamos N, Delliou E, Saratsiotou I, Ardavanis A, Mavroudis D, Skarpidi E, Arapantoni P, Karyda I, Patakioyta F, Aravantinos G, Razis E, Fountzilas G, Kosmidis P. Papadopoulos S, et al. Clin Breast Cancer. 2007 Oct;7(10):784-90. doi: 10.3816/CBC.2007.n.040. Clin Breast Cancer. 2007. PMID: 18021480
Small cell carcinoma of the stomach: A report of two cases and a review of the literature.
Bakogeorgos M, Kalkanis D, Katsaounis P, Ramfidis V, Speliades C, Pierrakou E, Papadopoulos S, Pantazopoulos N, Georgoulias V, Kotsakis A, Kentepozidis N. Bakogeorgos M, et al. Among authors: papadopoulos s. Mol Clin Oncol. 2018 Jul;9(1):11-16. doi: 10.3892/mco.2018.1624. Epub 2018 May 10. Mol Clin Oncol. 2018. PMID: 29896397 Free PMC article.
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Pectasides D, Kalogera-Fountzila A, Skarlos D, Kalofonos HP, Papadimitriou C, Bafaloukos D, Lambropoulos S, Papadopoulos S, Kourea H, Markopoulos C, Linardou H, Mavroudis D, Briasoulis E, Pavlidis N, Razis E, Kosmidis P, Gogas H. Fountzilas G, et al. Among authors: papadopoulos s. Breast Cancer Res Treat. 2005 Jul;92(1):1-9. doi: 10.1007/s10549-005-0322-y. Breast Cancer Res Treat. 2005. PMID: 15980985 Clinical Trial.
Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
Timotheadou E, Skarlos DV, Samantas E, Papadopoulos S, Murray S, Skrickova J, Christodoulou C, Papakostantinou C, Pectasides D, Papakostas P, Kaplanova J, Vrettou E, Karina M, Kosmidis P, Fountzilas G. Timotheadou E, et al. Among authors: papadopoulos s. Anticancer Res. 2007 Nov-Dec;27(6C):4481-9. Anticancer Res. 2007. PMID: 18214064 Free article.
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Malamou-Mitsi V, Gogas H, Dafni U, Bourli A, Fillipidis T, Sotiropoulou M, Vlachodimitropoulos D, Papadopoulos S, Tzaida O, Kafiri G, Kyriakou V, Markaki S, Papaspyrou I, Karagianni E, Pavlakis K, Toliou T, Scopa C, Papakostas P, Bafaloukos D, Christodoulou C, Fountzilas G. Malamou-Mitsi V, et al. Among authors: papadopoulos s. Ann Oncol. 2006 Oct;17(10):1504-11. doi: 10.1093/annonc/mdl147. Epub 2006 Sep 12. Ann Oncol. 2006. PMID: 16968874 Free article. Clinical Trial.
358 results